Who owns HALOZYME THERAPEUTICS?
- CUSIP Number: 40637had1
Tip: Access positions for across all investors
Analyze quarterly positions in Halozyme Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Halozyme Therapeutics stock
Who bought or sold HALOZYME THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| M&G | 39M | $43M | 5% | Jun 2026 |
|
| Steelhead Partners | 35M | $39B | 84% | Jun 2026 |
|
| Jpmorgan Chase & Co | 14M | $16M | 100% | Jun 2026 |
|
| Citadel Advisors | 12M | $13M | -39% | Jun 2026 |
|
| Silverback Asset Management | 11M | $12M | 0% | Jun 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 11M | $12M | 0% | Jun 2026 |
|
| Citigroup | 10M | $11M | 100% | Mar 2026 |
|
| Tpg Gp A | 10M | $11M | 0% | Jun 2026 |
|
| Point72 Asset Management | 7.5M | $8.4M | 0% | Jun 2026 |
|
| Balyasny Asset Management | 6.2M | $6.9M | 0% | Jun 2026 |
|
| Advent Capital Management | 5.7M | $6.3M | 100% | Jun 2026 |
|
| MacKay Shields | 5.4M | $6.0M | 0% | Jun 2026 |
|
| Calamos Advisors | 5.4M | $6.0M | -5% | Jun 2026 |
|
| Huntington Asset Advisors | 5.1M | $5.7M | 72% | Jun 2026 |
|
| Pier 88 Investment Partners | 5.1M | $5.7M | 72% | Jun 2026 |
|
| Colony | 3.7M | $4.1M | -1% | Jun 2026 |
|
| UBS Group | 3.2M | $3.6M | 4920% | Jun 2026 |
|
| Goldman Sachs Group | 2.8M | $3.1M | 100% | Jun 2026 |
|
| FMR | 2.4M | $2.6M | 1% | Jun 2026 |
|
| Bnp Paribas Investment Partners | 2.3M | $2.6M | -12% | Jun 2026 |
|
| Aequim Alternative Investments | 2.0M | $2.2M | 0% | Jun 2026 |
|
| Nomura Asset Management International | 1.8M | $2.0M | 100% | Jun 2026 |
|
| Man Group | 1.7M | $1.9M | -7% | Jun 2026 |
|
| Wells Fargo & Company | 1.4M | $1.6M | -1% | Jun 2026 |
|
| Ares Systematic Credit | 1.4M | $1.6M | 100% | Jun 2026 |
|
| SSI Investment Management | 1.3M | $1.4M | 0% | Jun 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 750k | $838k | 0% | Jun 2026 |
|
| Bank Of Montreal | 634k | $663k | 100% | Mar 2026 |
|
| Calamos Wealth Management | 272k | $304k | 2% | Jun 2026 |
|
| Oppenheimer Asset Management | 173k | $192k | 2% | Jun 2026 |
|
| Wiley Bros.-aintree Capital | 130k | $144k | 0% | Jun 2026 |
|
| Cutler Capital Management | 110k | $122k | 0% | Jun 2026 |
|
| Leucadia National Corporation | 100k | $112k | 100% | Jun 2026 |
|
| Capital Investment Advisory Services | 59k | $66k | 0% | Jun 2026 |
|
| Mariner Wealth Advisors | 59k | $66k | 0% | Jun 2026 |
|
| Stephens | 53k | $59k | 0% | Jun 2026 |
|
| Branch Banking & Trust Company | 38k | $42k | 0% | Jun 2026 |
|
| Barclays | 34k | $38k | 100% | Jun 2026 |
|
| Wealth Enhancement Advisory Services | 20k | $22k | 100% | Jun 2026 |
|
| Ameriprise Financial | 18k | $20k | -18% | Jun 2026 |
|
| Commonwealth Equity Services | 17k | $19k | -15% | Jun 2026 |
|
| Insigneo Advisory Services | 17k | $19k | 100% | Jun 2026 |
|
| MAI Wealth Advisors | 15k | $17k | 0% | Jun 2026 |
|
| Morgan Stanley | 15k | $16k | 0% | Mar 2026 |
|
| Goldstein Advisors | 14k | $16k | 0% | Jun 2026 |
|
| Raymond James Financial | 13k | $14k | -28% | Jun 2026 |
|
| Cetera Investment Advisers | 12k | $13k | 0% | Jun 2026 |
|
| Balboa Wealth Partners | 10k | $11k | -64% | Jun 2026 |
|
| Nbc Securities | 8.0k | $8.9k | 100% | Jun 2026 |
|
| Laffer Investments | 1.9k | $2.2M | -2% | Jun 2026 |
|
Who sold out of Halozyme Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nuveen | Mar 2026 | 12M | $13M |
| Water Island Capital | Mar 2026 | 3.0M | $3.1M |
| Flossbach Von Storch | Dec 2025 | 1.1M | $1.1M |
| Kohlberg Kravis Roberts & Co | Mar 2026 | 915k | $953k |
| Mml Investors Services | Mar 2026 | 18k | $19k |